Your browser doesn't support javascript.
loading
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Palanisamy, Nallasivam; Yang, Jun; Shepherd, Peter D A; Li-Ning-Tapia, Elsa M; Labanca, Estefania; Manyam, Ganiraju C; Ravoori, Murali K; Kundra, Vikas; Araujo, John C; Efstathiou, Eleni; Pisters, Louis L; Wan, Xinhai; Wang, Xuemei; Vazquez, Elba S; Aparicio, Ana M; Carskadon, Shannon L; Tomlins, Scott A; Kunju, Lakshmi P; Chinnaiyan, Arul M; Broom, Bradley M; Logothetis, Christopher J; Troncoso, Patricia; Navone, Nora M.
Afiliação
  • Palanisamy N; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
  • Yang J; Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Shepherd PDA; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li-Ning-Tapia EM; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Labanca E; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Manyam GC; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravoori MK; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kundra V; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Araujo JC; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Efstathiou E; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pisters LL; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wan X; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang X; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vazquez ES; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Aparicio AM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Carskadon SL; CONICET-Universidad de Buenos Aires. Instituto de Quimica Biologica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Buenos Aires, Argentina.
  • Tomlins SA; Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kunju LP; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
  • Chinnaiyan AM; Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Broom BM; Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Logothetis CJ; Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Troncoso P; Department of Pathology, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Navone NM; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(18): 4933-4946, 2020 09 15.
Article em En | MEDLINE | ID: mdl-32576626
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Medicina de Precisão / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Medicina de Precisão / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article